Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Arrhythmias

Free Subscription Articles published in J Thromb Thrombolysis Retrieve available abstracts of 31 articles: HTML format

Single Articles

July 2025
1. PEREIRA V, Marino M, Hornik A, Hornik J, et al
   Comparison of early vs late anticoagulation for secondary stroke prevention in patients with atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials.
   J Thromb Thrombolysis. 2025 Jul 29. doi: 10.1007/s11239-025-03139.
   PubMed     Abstract available
   
   
   
2. MARKIDES RIL, Koolaji S, Leader JH, Farag M, et al
   Safety of factor XI inhibitors compared to factor X inhibitors in atrial fibrillation: a systematic review and meta-analysis.
   J Thromb Thrombolysis. 2025 Jul 3. doi: 10.1007/s11239-025-03142.
   PubMed    
   
   
   May 2025
3. SAIRAKU A, Kimura Y, Nakano Y
   Clinical outcomes of off-label DOAC underdosing in Japanese patients with atrial fibrillation: a systematic review and meta-analysis.
   J Thromb Thrombolysis. 2025 May 29. doi: 10.1007/s11239-025-03107.
   PubMed     Abstract available
   
   
   April 2025
4. SETH L, Stabellini N, Doss S, Patel V, et al
   Atrial fibrillation and ischemic stroke in cancer: the latest scientific evidence, current management, and future directions.
   J Thromb Thrombolysis. 2025 Apr 26. doi: 10.1007/s11239-025-03104.
   PubMed     Abstract available
   
   
   
5. RAGIA G, Pallikarou M, Michou C, Thomopoulos T, et al
   Direct oral anticoagulants do not affect miR-27a-3p expression, a regulator of coagulation cascade, in atrial fibrillation patients.
   J Thromb Thrombolysis. 2025 Apr 21. doi: 10.1007/s11239-025-03102.
   PubMed     Abstract available
   
   
   
6. VICARIO T, Menichelli D, Mascolo AP, Diomedi M, et al
   The severity of ischemic stroke and risk of all-cause mortality in patients with atrial fibrillation on different oral anticoagulant treatments admitted to the emergency department.
   J Thromb Thrombolysis. 2025 Apr 5. doi: 10.1007/s11239-025-03095.
   PubMed     Abstract available
   
   
   February 2025
7. LIU Y, Lam SHM, Romiti GF, Huang B, et al
   Renal function and adverse clinical events in anticoagulated patients with atrial fibrillation: insights from the GLORIA-AF Registry Phase III.
   J Thromb Thrombolysis. 2025 Feb 9. doi: 10.1007/s11239-025-03067.
   PubMed     Abstract available
   
   
   October 2024
8. HUANG Q, Cheng W
   Letter to the editor to ''Elevated plasma protein carbonylation increases the risk of ischemic cerebrovascular events in patients with atrial fibrillation: association with a prothrombotic state''.
   J Thromb Thrombolysis. 2024 Oct 5. doi: 10.1007/s11239-024-03035.
   PubMed    
   
   
   
9. SMEETS MJR, Kristiansen EB, Nemeth B, Huisman MV, et al
   Risks of major bleeding and venous thromboembolism in patients undergoing total hip or total knee arthroplasty using therapeutic dosages of DOACs.
   J Thromb Thrombolysis. 2024;57:1249-1255.
   PubMed     Abstract available
   
   
   August 2024
10. CHEN KH, Hsu YY, Chou CY, Hsu CC, et al
    Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in low-weight patients with atrial fibrillation.
    J Thromb Thrombolysis. 2024 Aug 14. doi: 10.1007/s11239-024-03016.
    PubMed     Abstract available
    
    
    July 2024
11. KRITTAYAPHONG R, Winijkul A, Methavigul K, Chichareon P, et al
    Clinical outcomes of patients with atrial fibrillation in relation to multimorbidity status changes over time and the impact of ABC pathway compliance: a nationwide cohort study.
    J Thromb Thrombolysis. 2024 Jul 9. doi: 10.1007/s11239-024-03007.
    PubMed     Abstract available
    
    
    
12. NOWAK K, Zabczyk M, Natorska J, Zalewski J, et al
    Elevated plasma protein carbonylation increases the risk of ischemic cerebrovascular events in patients with atrial fibrillation: association with a prothrombotic state.
    J Thromb Thrombolysis. 2024 Jul 4. doi: 10.1007/s11239-024-03003.
    PubMed     Abstract available
    
    
    June 2024
13. PETERSON ME, Jaynes MP, Berardi S, Morton C, et al
    Evaluation of modified fixed dose four-factor prothrombin complex concentrate for warfarin reversal.
    J Thromb Thrombolysis. 2024;57:865-870.
    PubMed     Abstract available
    
    
    May 2024
14. LIP GYH, Noxon V, Kang A, Luo X, et al
    Effectiveness and safety in non-valvular atrial fibrillation patients switching from warfarin to direct oral anticoagulants in US healthcare claims.
    J Thromb Thrombolysis. 2024 May 2. doi: 10.1007/s11239-024-02976.
    PubMed     Abstract available
    
    
    April 2024
15. SADOWSKI M, Zabczyk M, Undas A
    Impaired fibrinolysis in patients with atrial fibrillation and elevated circulating lipopolysaccharide.
    J Thromb Thrombolysis. 2024 Apr 21. doi: 10.1007/s11239-024-02980.
    PubMed     Abstract available
    
    
    
16. MURAKAMI Y, Todo K, Uchida K, Yamagami H, et al
    One-year morbidity and mortality in patients treated with standard-dose and low-dose apixaban after acute large vessel occlusion stroke.
    J Thromb Thrombolysis. 2024;57:622-629.
    PubMed     Abstract available
    
    
    
17. MWITA JC, Francis JM, Pillay C, Ogah OS, et al
    Anticoagulation control among patients on vitamin K antagonists in nine countries in Sub-Saharan Africa.
    J Thromb Thrombolysis. 2024;57:613-621.
    PubMed     Abstract available
    
    
    
18. AKHAN O, Boz M, Guzel T, Kis M, et al
    Discrimination of the acute pulmonary embolism subtypes based on the novel MAPH score.
    J Thromb Thrombolysis. 2024;57:683-690.
    PubMed     Abstract available
    
    
    March 2024
19. TRUONG B, Hornsby L, Fox B, Chou C, et al
    Benefit and risk of oral anticoagulant initiation strategies in patients with atrial fibrillation and cancer: a target trial emulation using the SEER-Medicare database.
    J Thromb Thrombolysis. 2024 Mar 20. doi: 10.1007/s11239-024-02958.
    PubMed     Abstract available
    
    
    February 2024
20. GJERMENI D, Anfang V, Vetter H, Szabo S, et al
    Low on-clopidogrel ADP- and TRAP-6-induced platelet aggregation in patients with atrial fibrillation undergoing percutaneous coronary intervention: an observational pilot study.
    J Thromb Thrombolysis. 2024 Feb 12. doi: 10.1007/s11239-023-02937.
    PubMed     Abstract available
    
    
    
21. ZHOU Q, Liu X, Gu ZC, Yang X, et al
    Short-term antiplatelet versus anticoagulant therapy after left atrial appendage closure: a systematic review and meta-analysis.
    J Thromb Thrombolysis. 2024;57:194-203.
    PubMed     Abstract available
    
    
    January 2024
22. DE LUCENA LA, Freitas MAA, Souza AKC, Silva CHA, et al
    Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and stage 5 chronic kidney disease under dialysis: A systematic review and meta-analysis of randomized controlled trials.
    J Thromb Thrombolysis. 2024 Jan 28. doi: 10.1007/s11239-023-02945.
    PubMed     Abstract available
    
    
    
23. TRILLER DM, Wilson AS, Allen AL, Burnett AE, et al
    Digital dashboards for direct oral anticoagulant surveillance, intervention and operational efficiency: uptake, obstacles, and opportunities.
    J Thromb Thrombolysis. 2024;57:107-116.
    PubMed     Abstract available
    
    
    December 2023
24. D'ANNA L, Ornello R, Foschi M, Romoli M, et al
    Outcomes of mechanical thrombectomy in acute stroke patients with atrial fibrillation detected after stroke versus known atrial fibrillation.
    J Thromb Thrombolysis. 2023 Dec 21. doi: 10.1007/s11239-023-02923.
    PubMed     Abstract available
    
    
    
25. SALMASI S, Safari A, De Vera MA, Hogg T, et al
    Adherence to direct or vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a long-term observational study.
    J Thromb Thrombolysis. 2023 Dec 16. doi: 10.1007/s11239-023-02921.
    PubMed     Abstract available
    
    
    November 2023
26. MIZOBUCHI S, Kojima K, Miyagawa M, Tanaka Y, et al
    Association between aortic thrombi detected using non-obstructive general angioscopy and atrial fibrillation.
    J Thromb Thrombolysis. 2023 Nov 28. doi: 10.1007/s11239-023-02917.
    PubMed     Abstract available
    
    
    
27. WESTREICH R, Tsaban G, Barrett O, Kezerle L, et al
    Estimated glomerular filtration rate and the risk of stroke in individuals with diabetes mellitus and atrial fibrillation insight from a large contemporary population study.
    J Thromb Thrombolysis. 2023 Nov 9. doi: 10.1007/s11239-023-02913.
    PubMed     Abstract available
    
    
    October 2023
28. LEIVA O, How J, Grevet J, Brunner A, et al
    In-Hospital and readmission outcomes of patients with myeloproliferative neoplasms and atrial fibrillation: insights from the National Readmissions Database.
    J Thromb Thrombolysis. 2023 Oct 15. doi: 10.1007/s11239-023-02900.
    PubMed     Abstract available
    
    
    
29. LIU G, Chen T, Zhang X, Hu B, et al
    Causal effect of atrial fibrillation on pulmonary embolism: a mendelian randomization study.
    J Thromb Thrombolysis. 2023 Oct 15. doi: 10.1007/s11239-023-02903.
    PubMed     Abstract available
    
    
    
30. DING WY, Fawzy AM, Romiti GF, Proietti M, et al
    Correction: Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry.
    J Thromb Thrombolysis. 2023 Oct 9. doi: 10.1007/s11239-023-02904.
    PubMed    
    
    
    September 2023
31. LILJA J, Sjalander A, Sjalander S
    Prevalence of atrial fibrillation and reasons for undertreatment with oral anticoagulants.
    J Thromb Thrombolysis. 2023 Sep 13. doi: 10.1007/s11239-023-02890.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Arrhythmias is free of charge.